Patents by Inventor Milton Pressler

Milton Pressler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070254832
    Abstract: The invention provides an AIM-lipid complex for treating age-related macular degeneration and related conditions. The compositions and methods of the instant invention encompass a novel approach to the treatment of age-related macular degeneration and related conditions. Pharmaceutical compositions for this use are also provided.
    Type: Application
    Filed: February 15, 2007
    Publication date: November 1, 2007
    Inventors: Milton Pressler, William Sasiela, Jorge Arroyo, Peter Ganz, Mark Creager
  • Publication number: 20050245506
    Abstract: Combinations of diuretics and vasopressin antagonists are useful to slow and reverse the symptoms and process of congestive heart failure, to increase the excretion of water in the urine, and to decrease the excretion of sodium and potassium ions in urine. Preferred vasopressin antagonists have the formula wherein R and R5 are hydrogen or lower alkyl; R1, R2, and R3 are hydrogen, halo, alkyl, alkoxy, and amino; and R4 is hydrogen or phenyl, and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 16, 2005
    Publication date: November 3, 2005
    Inventors: Rebecca Bakker-Arkema, Milton Pressler
  • Publication number: 20050234043
    Abstract: Combinations of ACE inhibitors and vasopressin antagonists are useful to slow and reverse the process of ventricular dilation, and CHF in mammals.
    Type: Application
    Filed: June 14, 2005
    Publication date: October 20, 2005
    Inventor: Milton Pressler
  • Publication number: 20050191278
    Abstract: The invention provides a method of treating coronary artery disease in a human patient comprising directly injecting into an ischemic cardiac muscle, via multiple injections to different points of the cardiac muscle, a dose of a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a replication-deficient adenoviral vector comprising a nucleic acid sequence encoding an angiogenic peptide operably linked to a promoter, whereby the coronary artery disease is treated.
    Type: Application
    Filed: April 12, 2005
    Publication date: September 1, 2005
    Applicants: GenVec, Inc., Warner-Lambert Company
    Inventors: Milton Pressler, Donald Black, Paul Fischer, Henrik Rasmussen, Margaret Samyn, Grant Yonehiro